In the week of November 2, 2026, 86 public companies reported leadership changes to the SEC under Item 5.02 of Form 8-K, including 8 chief executive and 15 chief financial officer changes. They include Pfizer Inc, Sysco Corp, Federal National Mortgage Association Fannie Mae (Form 8-K, November 3, 2026).
86 public companies reported a change among their directors or officers the week of 2026-11-02. 71 changes name the person, including 8 at chief executive and 15 at chief financial officer.
| Company | Change | Person | Role | Effective | Filing |
|---|---|---|---|---|---|
| Pfizer Inc | Appointed | Cecile Guegan | Chief Financial Officer | 2026-11-01 | 8-K |
| Sysco Corp | Appointed | Brandon E. Sewell | Chief Financial Officer | 2026-11-01 | 8-K |
| Astec Industries Inc | Departing | Linda Knoll | 2026-12-14 | 8-K | |
| Astec Industries Inc | Appointed | John Keating | Director | 2026-12-11 | 8-K |
| Astec Industries Inc | Appointed | John Keating | 2026-12-11 | 8-K | |
| Trimble Inc. | Appointed | Matthew C. Brown | Director | 2026-11-02 | 8-K |
| Concord Acquisition Corp II | Departing | Michele Cito | Chief Financial Officer | 2026-10-28 | 8-K |
| Yum China Holdings, Inc. | Appointed | Alexander Dimitrief | Director | 2026-11-04 | 8-K |
| Phoenix Education Partners, Inc. | Appointed | Michael Weston | Director | 8-K | |
| First American Financial Corp | Appointed | Darryl D. Button | 8-K | ||
| Willis Towers Watson Plc | Appointed | Steven Alcock | Principal Accounting Officer | 2027-04-01 | 8-K |
| Guardant Health, Inc. | Appointed | Kevin R. Sayer | Director | 2026-11-02 | 8-K |
| Guardant Health, Inc. | Appointed | Robert A. Parks | Chief Accounting Officer | 8-K | |
| Federal Home Loan Bank of Dallas | Appointed | Max S. Yates | Director | 8-K | |
| Federal Home Loan Bank of Dallas | Appointed | James D. Goudge | Director | 8-K | |
| Chegg, Inc | Departing | Marcela Martin | Director | 2026-12-10 | 8-K |
| Picard Medical, Inc. | Appointed | Richard Fang | Chief Executive Officer | 8-K | |
| BNB Standard Corp | Appointed | Anthony Scaramucci | Director | 8-K | |
| BNB Standard Corp | Appointed | Anthony Scaramucci | 8-K | ||
| Elite Pharmaceuticals Inc /Nv/ | Appointed | Aqeel A. Fatmi | Director | 2026-10-28 | 8-K |
| Ocean Capital Acquisition Corp | Appointed | Yiyan Li | Chief Executive Officer | 8-K | |
| Ocean Capital Acquisition Corp | Appointed | Stephen J. Posner | Director | 8-K | |
| Erie Indemnity Co | Appointed | Brian W. Bolash | President and Chief Executive Officer | 2026-11-03 | 8-K |
| Toast, Inc. | Appointed | Michael Senno | Chief Financial Officer | 2027-01-01 | 8-K |
| Visium Technologies, Inc. | Departing | Kevin Yates | Director | 8-K/A | |
| Optimum Communications, Inc. | Appointed | Elizabeth Abrams | Director | 8-K | |
| Anavex Life Sciences Corp. | Appointed | Terrie Kellmeyer | Chief Executive Officer | 8-K | |
| Anavex Life Sciences Corp. | Appointed | Terrie Kellmeyer | 8-K | ||
| QuidelOrtho Corp | Appointed | Jonathan Siegrist | 2026-11-09 | 8-K | |
| Intuitive Surgical Inc | Appointed | Aaron Martin | 2027-01-01 | 8-K | |
| Lennox International Inc | Departing | Joseph F. Nassab | Executive Vice President | 8-K | |
| Ur-Energy Inc | Departing | Roger L. Smith | Chief Financial Officer and Chief Administrative Officer | 2026-12-01 | 8-K |
| Coronado Global Resources Inc. | Appointed | Sandeep Deoji | Chief Financial Officer | 2026-11-01 | 8-K |
| Fluence Energy, Inc. | Departing | Axel Meier | Director | 8-K | |
| Fluence Energy, Inc. | Appointed | Ricardo Roizen | Chief Financial Officer | 8-K | |
| TE Connectivity plc | Departing | John S. Jenkins | Chief Legal Officer | 8-K | |
| Indivior Pharmaceuticals, Inc. | Departing | Joseph Ciaffoni | Chief Executive Officer | 8-K | |
| Femasys Inc | Departing | Kenneth D. Eichenbaum | Director | 8-K | |
| Femasys Inc | Appointed | John Moorhead | Director | 8-K | |
| Femasys Inc | Appointed | John Moorhead | 8-K | ||
| Opendoor Technologies Inc. | Appointed | Michael Alfred | Director | 8-K/A | |
| Telos Corp | Appointed | Mark D. Griffin | President and Chief Executive Officer | 8-K | |
| Axe Compute Inc. | Appointed | Christopher Miglino | Chair of the Board | 2026-11-01 | 8-K |
| Global Indemnity Group, LLC | Departing | Bruce Lederman | 2026-10-26 | 8-K | |
| Global Indemnity Group, LLC | Appointed | Jessica E. Buss | Director | 8-K | |
| CSB Bancorp, Inc. | Departing | Paula J. Meiler | Chief Financial Officer | 2027-04-30 | 8-K |
| Syndax Pharmaceuticals Inc | Departing | Keith A. Goldan | Chief Financial Officer | 2026-11-09 | 8-K |
| Lindsay Corp | Appointed | Michael Koch | Chief Financial Officer | 2026-11-09 | 8-K |
| Frontier Group Holdings, Inc. | Appointed | Michael Delehant | Chief Operating Officer | 8-K | |
| PodcastOne, Inc. | Departing | Ramin Arani | Director | 8-K | |
| LiveOne, Inc. | Departing | Ramin Arani | Director | 8-K | |
| Federal Home Loan Bank of Chicago | Appointed | Virxhini Gjonzeneli | President | 2027-01-01 | 8-K |
| Greenlight Capital Re, Ltd. | Departing | Joseph Platt | Director | 2026-12-31 | 8-K |
| Greenlane Holdings, Inc. | Appointed | Peter Kampian | Director | 8-K | |
| Keysight Technologies, Inc. | Appointed | Jason Kary | Chief Financial Officer | 2026-12-18 | 8-K |
| Keysight Technologies, Inc. | Departing | Neil Dougherty | Chief Financial Officer | 8-K | |
| Recursion Pharmaceuticals, Inc. | Appointed | Fred Hassan | Chair of the Board | 8-K | |
| Recursion Pharmaceuticals, Inc. | Appointed | Fred Hassan | 8-K | ||
| Ziprecruiter, Inc. | Departing | Emily McEvilly | 8-K | ||
| Ziprecruiter, Inc. | Appointed | Jeffrey Liaw | 8-K | ||
| Ziprecruiter, Inc. | Appointed | Jeffrey Liaw | Director | 8-K | |
| Upwork, Inc | Departing | Erica Gessert | Chief Financial Officer | 2027-01-01 | 8-K |
| Upwork, Inc | Appointed | Peter Sanborn | Chief Financial Officer | 8-K | |
| 10x Genomics, Inc. | Appointed | Joseph Gilliam | 8-K | ||
| Hinge Health, Inc. | Departing | James Pursley | President | 2027-01-01 | 8-K |
| Hinge Health, Inc. | Appointed | James Pursley | Director | 2027-01-04 | 8-K |
| Hinge Health, Inc. | Appointed | Daniel Perez | President | 8-K | |
| Commercial Vehicle Group, Inc. | Appointed | David Ruppel | President and Chief Executive Officer | 2026-11-09 | 8-K |
| Commercial Vehicle Group, Inc. | Departing | James R. Ray | President and Chief Executive Officer | 2026-11-09 | 8-K |
| Xeris Biopharma Holdings, Inc. | Appointed | Menassie Taddese | 2026-11-02 | 8-K | |
| PACIFIC GAS & ELECTRIC Co | Appointed | Margaret K. Becker | Chief Financial Officer | 2027-01-01 | 8-K |
Also filed that week
Federal National Mortgage Association Fannie Mae Accendra Health Inc/Va/ Macrogenics Inc International Flavors & Fragrances Inc Beacon Financial Corp Guardant Health, Inc. Alamar Biosciences, Inc. BGC Group, Inc. Federal Home Loan Bank of Topeka Primoris Services Corp Guerrilla RF, Inc. Tevogen Inc. SiriusPoint Ltd Flywire Corp Ring Energy, Inc. ATN International, Inc. Concentrix Corp Enovix Corp Apogee Enterprises, Inc. Mid Penn Bancorp Inc Kenvue Inc. Colony Bankcorp Inc Kimberly Clark Corp LiveRamp Holdings, Inc. LXP Industrial Trust Advantage Solutions Inc. Lumentum Holdings Inc. CBIZ, Inc. BHAV Acquisition Corp II Pvh Corp. /De/ Greystone Logistics, Inc. Daily Journal Corp Valion Bio, Inc. Anavex Life Sciences Corp.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.